Carbonic anhydrase inhibitors. Synthesis of 2,4,6-trimethylpyridinium derivatives of 2-(hydrazinocarbonyl)-3-aryl-1H-indole-5-sulfonamides acting as potent inhibitors of the tumor-associated isoform IX and XII

被引:22
|
作者
Guzel, Ozlen [1 ,2 ]
Maresca, Alfonso [1 ]
Scozzafava, Andrea [1 ]
Salman, Aydin [2 ]
Balaban, Alexandru T. [3 ]
Supuran, Claudiu T. [1 ]
机构
[1] Univ Florence, Lab Chim Bioinorgan, Rm 188,Via Lastruccia 3, I-50019 Florence, Italy
[2] Istanbul Univ, Fac Pharm, Dept Pharmaceut Chem, TR-34116 Istanbul, Turkey
[3] Texas A&M Univ, Galveston, TX 77551 USA
关键词
Carbonic anhydrase; Tumor-associated isoform; CA IX; CA XII; Sulfonamide; Pyridinium salt; Antitumor agent; IN-VIVO SELECTIVITY; X-RAY; ISOZYME-II; THERAPEUTIC APPLICATIONS; ANTITUMOR SULFONAMIDE; MAMMALIAN ISOFORMS; CA-IX; DESIGN; TARGET; IV;
D O I
10.1016/j.bmcl.2009.04.068
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of 2-(hydrazinocarbonyl)-3-aryl-1H-indole-5-sulfonamides possessing various 2-, 3- or 4- substituted phenyl groups with methyl-, halogeno- and methoxy-functionalities, or a perfluorophenyl moiety, has been derivatized by reaction with 2,4,6-trimethylpyrylium perchlorate. The new sulfonamides were evaluated as inhibitors of four mammalian carbonic anhydrase (CA, EC 4.2.1.1) isoforms, that is, CA I, II (cytosolic), CA IX and XII (transmembrane, tumor-associated forms). Excellent inhibitory activity was observed against hCA IX with most of these sulfonamides, and against hCA XII with some of the new compounds. These compounds were generally less effective inhibitors of hCA II. Being membrane impermeant, these positively-charged sulfonamides are interesting candidates for targeting the tumor-associated CA IX and XII, as possible diagnostic tools or therapeutic agents. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2931 / 2934
页数:4
相关论文
共 34 条
  • [21] S-substituted 2-mercaptoquinazolin-4(3H)-one and 4-ethylbenzensulfonamides act as potent and selective human carbonic anhydrase IX and XII inhibitors
    El-Azab, Adel S.
    Abdel-Aziz, Alaa A. -M.
    Bua, Silvia
    Nocentini, Alessio
    AlSaif, Nawaf A.
    Alanazi, Mohammed M.
    El-Gendy, Manal A.
    Ahmed, Hany E. A.
    Supuran, Claudiu T.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2020, 35 (01) : 733 - 743
  • [22] Carbonic anhydrase inhibitors. Regioselective synthesis of novel 1-substituted 1,4-dihydro-4-oxo-3-pyridinesulfonamides and their inhibition of the human cytosolic isozymes I and II and transmembrane cancer-associated isozymes IX and XII
    Brzozowski, Zdzislaw
    Slawinski, Jaroslaw
    Innocenti, Alessio
    Supuran, Claudiu T.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (09) : 3656 - 3661
  • [23] Exploring of tumor-associated carbonic anhydrase isoenzyme IX and XII inhibitory effects and cytotoxicities of the novel N-aryl-1-(4-sulfamoylphenyl)-5-(thiophen-2-yl)-1H-pyrazole-3-carboxamides
    Yamali, Cem
    Gul, Halise Inci
    Ozli, Gulsen
    Angeli, Andrea
    Kirmizibayrak, Petek Ballar
    Tepedelen, Burcu Erbaykent
    Sakagami, Hiroshi
    Bua, Silvia
    Supuran, Claudiu T.
    BIOORGANIC CHEMISTRY, 2021, 115
  • [24] Carbonic anhydrase inhibitors. Regioselective synthesis of novel series 1-substituted 1,4-dihydro-4-oxo-3-pyridinesulfonamides and their inhibition of the human cytosolic isozymes I and II and transmembrane cancer-associated isozymes IX and XII
    Brzozowski, Zdzislaw
    Slawinski, Jaroslaw
    Vullo, Daniela
    Supuran, Claudiu T.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 56 : 282 - 291
  • [25] Inhibition of human carbonic anhydrase isozymes I, II, IX and XII with a new series of sulfonamides incorporating aroylhydrazone-, [1,2,4]triazolo[3,4-b][1,3,4]thiadiazinyl- or 2-(cyanophenylmethylene)-1,3,4-thiadiazol-3(2H)-yl moieties
    Alafeefy, Ahmed M.
    Abdel-Aziz, Hatem A.
    Vullo, Daniela
    Al-Tamimi, Abdul-Malek S.
    Awaad, Amani S.
    Mohamed, Menshawy A.
    Capasso, Clemente
    Supuran, Claudiu T.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2015, 30 (01) : 52 - 56
  • [26] Synthesis and exploration of 2-morpholino-4-phenylthiazol-5-yl acrylamide derivatives for their effects against carbonic anhydrase I, II, IX and XII isoforms as a non-sulfonamide class of inhibitors
    Swain, Baijayantimala
    Digwal, Chander Singh
    Angeli, Andrea
    Alvala, Mallika
    Singh, Priti
    Supuran, Claudiu T.
    Arifuddin, Mohammed
    BIOORGANIC & MEDICINAL CHEMISTRY, 2019, 27 (21)
  • [27] Novel 2-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies
    Zolnowska, Beata
    Slawinski, Jaroslaw
    Szafranski, Krzysztof
    Angeli, Andrea
    Supuran, Claudiu T.
    Kawiak, Anna
    Wieczor, Milosz
    Zielinska, Joanna
    Baczek, Tomasz
    Bartoszewska, Sylwia
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 143 : 1931 - 1941
  • [28] Discovery of first-in-class multi-target adenosine A2A receptor antagonists-carbonic anhydrase IX and XII inhibitors. 8-Amino-6-aryl-2-phenyl-1,2,4-triazolo [4,3-a]pyrazin-3-one derivatives as new potential antitumor agents
    Ceni, Costanza
    Catarzi, Daniela
    Varano, Flavia
    Dal Ben, Diego
    Marucci, Gabriella
    Buccioni, Michela
    Volpini, Rosaria
    Angeli, Andrea
    Nocentini, Alessio
    Gratteri, Paola
    Supuran, Claudiu T.
    Colotta, Vittoria
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 201
  • [29] Synthesis, cytotoxic, and carbonic anhydrase inhibitory effects of new 2-(3-(4-methoxyphenyl)-5-(aryl)-4,5-dihydro-1H-pyrazol-1-yl)benzo[d]thiazole derivatives
    Tugrak, Mehtap
    Gul, Halise Inci
    Sakagami, Hiroshi
    Gulcin, Ilhami
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 2020, 57 (07) : 2762 - 2768
  • [30] Synthesis and Carbonic Anhydrase Inhibition of Novel 2-(4-(Aryl)thiazole-2-yl)-3a,4,7,7a-tetrahydro-1H-4,7-methanoisoindole-1,3(2H)-dione Derivatives
    Kocyigit, Umit M.
    Aslan, Osman Nuri
    Gulcin, Ilhami
    Temel, Yusuf
    Ceylan, Mustafa
    ARCHIV DER PHARMAZIE, 2016, 349 (12) : 955 - 963